104 related articles for article (PubMed ID: 10428485)
1. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells.
Kranewitter WJ; Gimona M
FEBS Lett; 1999 Jul; 455(1-2):123-9. PubMed ID: 10428485
[TBL] [Abstract][Full Text] [Related]
2. Critical role of the pleckstrin homology and cysteine-rich domains in Vav signaling and transforming activity.
Palmby TR; Abe K; Der CJ
J Biol Chem; 2002 Oct; 277(42):39350-9. PubMed ID: 12177050
[TBL] [Abstract][Full Text] [Related]
3. GEF at work: Vav in protruding filopodia.
Kranewitter WJ; Danninger C; Gimona M
Cell Motil Cytoskeleton; 2001 Jul; 49(3):154-60. PubMed ID: 11668584
[TBL] [Abstract][Full Text] [Related]
4. Does Vav bind to F-actin through a CH domain?
Castresana J; Saraste M
FEBS Lett; 1995 Oct; 374(2):149-51. PubMed ID: 7589522
[TBL] [Abstract][Full Text] [Related]
5. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.
Khosravi-Far R; Chrzanowska-Wodnicka M; Solski PA; Eva A; Burridge K; Der CJ
Mol Cell Biol; 1994 Oct; 14(10):6848-57. PubMed ID: 7935402
[TBL] [Abstract][Full Text] [Related]
6. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins.
Movilla N; Bustelo XR
Mol Cell Biol; 1999 Nov; 19(11):7870-85. PubMed ID: 10523675
[TBL] [Abstract][Full Text] [Related]
7. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
8. Autoinhibition mechanism of proto-Dbl.
Bi F; Debreceni B; Zhu K; Salani B; Eva A; Zheng Y
Mol Cell Biol; 2001 Mar; 21(5):1463-74. PubMed ID: 11238883
[TBL] [Abstract][Full Text] [Related]
9. Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity.
Abe K; Whitehead IP; O'Bryan JP; Der CJ
J Biol Chem; 1999 Oct; 274(43):30410-8. PubMed ID: 10521418
[TBL] [Abstract][Full Text] [Related]
10. Vav links antigen-receptor signaling to the actin cytoskeleton.
Fischer KD; Tedford K; Penninger JM
Semin Immunol; 1998 Aug; 10(4):317-27. PubMed ID: 9695188
[TBL] [Abstract][Full Text] [Related]
11. Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton.
Dombroski D; Houghtling RA; Labno CM; Precht P; Takesono A; Caplen NJ; Billadeau DD; Wange RL; Burkhardt JK; Schwartzberg PL
J Immunol; 2005 Feb; 174(3):1385-92. PubMed ID: 15661896
[TBL] [Abstract][Full Text] [Related]
12. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.
Das B; Shu X; Day GJ; Han J; Krishna UM; Falck JR; Broek D
J Biol Chem; 2000 May; 275(20):15074-81. PubMed ID: 10748082
[TBL] [Abstract][Full Text] [Related]
13. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.
Holsinger LJ; Graef IA; Swat W; Chi T; Bautista DM; Davidson L; Lewis RS; Alt FW; Crabtree GR
Curr Biol; 1998 May; 8(10):563-72. PubMed ID: 9601640
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization and regulation of the vav proto-oncogene.
Denkinger DJ; Borges CR; Butler CL; Cushman AM; Kawahara RS
Biochim Biophys Acta; 2000 Apr; 1491(1-3):253-62. PubMed ID: 10760587
[TBL] [Abstract][Full Text] [Related]
15. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
16. Live dynamics of GFP-calponin: isoform-specific modulation of the actin cytoskeleton and autoregulation by C-terminal sequences.
Danninger C; Gimona M
J Cell Sci; 2000 Nov; 113 Pt 21():3725-36. PubMed ID: 11034901
[TBL] [Abstract][Full Text] [Related]
17. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
Katzav S; Cleveland JL; Heslop HE; Pulido D
Mol Cell Biol; 1991 Apr; 11(4):1912-20. PubMed ID: 2005887
[TBL] [Abstract][Full Text] [Related]
18. Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity.
Yabana N; Shibuya M
Oncogene; 2002 Oct; 21(50):7720-9. PubMed ID: 12400014
[TBL] [Abstract][Full Text] [Related]
19. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
20. The single CH domain of calponin is neither sufficient nor necessary for F-actin binding.
Gimona M; Mital R
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1813-21. PubMed ID: 9625744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
